126 related articles for article (PubMed ID: 32538033)
1. Early Initiation of ARV Therapy Among TB-HIV Patients in Indonesia Prolongs Survival Rates!
Maemun S; Mariana N; Rusli A; Mahkota R; Purnama TB
J Epidemiol Glob Health; 2020 Jun; 10(2):164-167. PubMed ID: 32538033
[TBL] [Abstract][Full Text] [Related]
2. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
Azeez A; Mutambayi R; Odeyemi A; Ndege J
Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
[TBL] [Abstract][Full Text] [Related]
3. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
Muyaya LM; Musanda EM; Tamuzi JL
BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
[TBL] [Abstract][Full Text] [Related]
5. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
[TBL] [Abstract][Full Text] [Related]
6. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
Atalell KA; Birhan Tebeje N; Ekubagewargies DT
PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
[TBL] [Abstract][Full Text] [Related]
7. [Treatment outcome, survival and their risk factors among new tuberculosis patients co-infected with HIV during the Ebola outbreak in Conakry].
Camara A; Sow MS; Touré A; Diallo OH; Kaba I; Bah B; Diallo TH; Diallo MS; Guilavogui T; Sow OY
Rev Epidemiol Sante Publique; 2017 Nov; 65(6):419-426. PubMed ID: 29066256
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.
Abay SM; Deribe K; Reda AA; Biadgilign S; Datiko D; Assefa T; Todd M; Deribew A
J Int Assoc Provid AIDS Care; 2015; 14(6):560-70. PubMed ID: 26289343
[TBL] [Abstract][Full Text] [Related]
10. Survival rate and mortality risk factors among TB-HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study.
Aung ZZ; Saw YM; Saw TN; Oo N; Aye HNN; Aung S; Oo HN; Cho SM; Khaing M; Kariya T; Yamamoto E; Hamajima N
Int J Infect Dis; 2019 Mar; 80():10-15. PubMed ID: 30572021
[TBL] [Abstract][Full Text] [Related]
11. [Effect of antiretroviral therapy in reducing deaths among patients co-infected with Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi].
Zheng Z; Cui Z; Huang M; Pan D
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Feb; 36(2):124-7. PubMed ID: 25907719
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
13. Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.
Burnett SM; Zawedde-Muyanja S; Hermans SM; Weaver MR; Colebunders R; Manabe YC
J Acquir Immune Defic Syndr; 2018 Dec; 79(5):605-611. PubMed ID: 30383587
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
Muyaya LM; Young T; Loveday M
Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
[TBL] [Abstract][Full Text] [Related]
15. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
Herce ME; Morse J; Luhanga D; Harris J; Smith HJ; Besa S; Samungole G; Kancheya N; Muyoyeta M; Reid SE
BMC Infect Dis; 2018 Oct; 18(1):536. PubMed ID: 30367622
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
Parchure R; Kulkarni V; Gangakhedkar R; Swaminathan S
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1348-1353. PubMed ID: 27725046
[TBL] [Abstract][Full Text] [Related]
17. Adjusting the Effect of Integrating Antiretroviral Therapy and Tuberculosis Treatment on Mortality for Noncompliance: A Time-varying Instrumental Variables Analysis.
Yende-Zuma N; Mwambi H; Vansteelandt S
Epidemiology; 2019 Mar; 30(2):197-203. PubMed ID: 30720587
[TBL] [Abstract][Full Text] [Related]
18. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
[TBL] [Abstract][Full Text] [Related]
19. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Tshitenge S; Ogunbanjo GA; Citeya A
Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil.
Moreira J; Castro R; Lamas C; Ribeiro S; Grinsztejn B; Veloso VG
Int J Infect Dis; 2018 Apr; 69():11-19. PubMed ID: 29253707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
